IL129337A0 - Bicyclic aryl carboxamides and their therapeutic use - Google Patents
Bicyclic aryl carboxamides and their therapeutic useInfo
- Publication number
- IL129337A0 IL129337A0 IL12933797A IL12933797A IL129337A0 IL 129337 A0 IL129337 A0 IL 129337A0 IL 12933797 A IL12933797 A IL 12933797A IL 12933797 A IL12933797 A IL 12933797A IL 129337 A0 IL129337 A0 IL 129337A0
- Authority
- IL
- Israel
- Prior art keywords
- therapeutic use
- bicyclic aryl
- aryl carboxamides
- carboxamides
- bicyclic
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- -1 Bicyclic aryl carboxamides Chemical class 0.000 title 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 abstract 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9623860.5A GB9623860D0 (en) | 1996-11-15 | 1996-11-15 | Novel compounds |
| GBGB9708062.6A GB9708062D0 (en) | 1997-04-22 | 1997-04-22 | Novel compounds |
| PCT/GB1997/003154 WO1998022460A1 (en) | 1996-11-15 | 1997-11-17 | Bicyclic aryl carboxamides and their therapeutic use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL129337A0 true IL129337A0 (en) | 2000-02-17 |
Family
ID=26310411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12933797A IL129337A0 (en) | 1996-11-15 | 1997-11-17 | Bicyclic aryl carboxamides and their therapeutic use |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US6353010B1 (cs) |
| EP (1) | EP0944616B1 (cs) |
| JP (1) | JP2001504479A (cs) |
| KR (1) | KR20000053274A (cs) |
| CN (1) | CN1114604C (cs) |
| AT (1) | ATE242234T1 (cs) |
| AU (1) | AU726590B2 (cs) |
| BR (1) | BR9713507A (cs) |
| CA (1) | CA2268037A1 (cs) |
| CZ (1) | CZ158299A3 (cs) |
| DE (1) | DE69722656T2 (cs) |
| DK (1) | DK0944616T3 (cs) |
| ES (1) | ES2200163T3 (cs) |
| HU (1) | HUP0000189A3 (cs) |
| ID (1) | ID21698A (cs) |
| IL (1) | IL129337A0 (cs) |
| NO (1) | NO992337D0 (cs) |
| NZ (1) | NZ335197A (cs) |
| RU (1) | RU2176642C2 (cs) |
| SK (1) | SK283534B6 (cs) |
| TR (1) | TR199901730T2 (cs) |
| WO (1) | WO1998022460A1 (cs) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000198734A (ja) * | 1998-12-30 | 2000-07-18 | Pfizer Inc | 胃運動性減弱および関連疾患の治療のための運動性増強薬 |
| GB0003254D0 (en) * | 2000-02-11 | 2000-04-05 | Darwin Discovery Ltd | Heterocyclic compounds and their therapeutic use |
| GB0003256D0 (en) * | 2000-02-11 | 2000-04-05 | Darwin Discovery Ltd | Heterocyclic compounds and their therapeutic use |
| ATE417038T1 (de) * | 2001-06-15 | 2008-12-15 | Astellas Pharma Inc | Phenylpyridincarbonyl piperazinderivate |
| MX342777B (es) * | 2002-07-19 | 2016-10-12 | Abbvie Biotechnology Ltd | Inhibidores tnfa para usarse en el tratamiento de trastornos relacionados con tnfa. |
| CA2548172A1 (en) | 2003-12-04 | 2005-06-23 | Vertex Pharmaceuticals Incorporated | Quinoxalines useful as inhibitors of protein kinases |
| WO2005087749A1 (ja) * | 2004-03-15 | 2005-09-22 | Kyowa Hakko Kogyo Co., Ltd. | ２−アミノキナゾリン誘導体 |
| JP2008530234A (ja) | 2005-02-17 | 2008-08-07 | エーエムアール テクノロジー，インコーポレーテッド | Ｃｉｎｖ及びｉｂｓ−ｄ治療用のベンゾオキサゾールカルボキサミド |
| MX2007011234A (es) * | 2005-03-14 | 2007-11-12 | Transtech Pharma Inc | Derivados de benzazol, composiciones y metodos de uso en la forma de inhibidores de b-secretasa. |
| NZ595225A (en) | 2005-05-16 | 2013-05-31 | Abbott Biotech Ltd | Use of tnf inhibitor for treatment of erosive polyarthritis |
| CA2642610A1 (en) * | 2006-02-20 | 2007-08-30 | Astellas Pharma Inc. | Amide derivative or salt thereof |
| US9624295B2 (en) | 2006-04-10 | 2017-04-18 | Abbvie Biotechnology Ltd. | Uses and compositions for treatment of psoriatic arthritis |
| US9605064B2 (en) | 2006-04-10 | 2017-03-28 | Abbvie Biotechnology Ltd | Methods and compositions for treatment of skin disorders |
| US7553846B2 (en) * | 2006-08-07 | 2009-06-30 | Albany Molecular Research, Inc. | 2-alkylbenzoxazole carboxamides as 5-HT3 modulators |
| JPWO2008026687A1 (ja) | 2006-09-01 | 2010-01-21 | 杏林製薬株式会社 | ピラゾロピリジンカルボキサミド誘導体及びそれらを含有するホスホジエステラーゼ（ｐｄｅ）阻害剤 |
| US8293923B2 (en) * | 2006-09-07 | 2012-10-23 | Biogen Idec Ma Inc. | Indazole derivatives as modulators of interleukin-1 receptor-associated kinase |
| WO2008154543A2 (en) | 2007-06-11 | 2008-12-18 | Abbott Biotechnology Ltd. | Methods for treating juvenile idiopathic arthritis |
| TWI444379B (zh) | 2007-06-29 | 2014-07-11 | Sunesis Pharmaceuticals Inc | 有用於作為Ｒａｆ激酶抑制劑之化合物 |
| SI2401267T1 (sl) | 2009-02-27 | 2014-05-30 | Ambit Biosciences Corporation | Derivati kinazolina, ki modulirajo JAK-kinazo, in njihova uporaba v postopkih |
| KR20130102060A (ko) | 2010-09-01 | 2013-09-16 | 암비트 바이오사이언시즈 코포레이션 | 퀴나졸린 화합물 및 이의 사용 방법 |
| CN104428293B (zh) * | 2012-06-11 | 2018-06-08 | Ucb生物制药私人有限公司 | 调节TNFα的苯并咪唑类 |
| CA2883574A1 (en) * | 2012-09-05 | 2014-03-13 | Bayer Cropscience Ag | Use of substituted 2-amidobenzimidazoles, 2-amidobenzoxazoles and 2-amidobenzothiazoles or salts thereof as active substances against abiotic plant stress |
| CN108440333A (zh) * | 2018-03-29 | 2018-08-24 | 江苏道博化工有限公司 | 分散染料中间体的合成方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS50140442A (cs) | 1974-04-16 | 1975-11-11 | ||
| ZA841076B (en) | 1983-02-14 | 1984-09-26 | Usv Pharma Corp | Benzoheterocyclic carbamates |
| DE3835660A1 (de) * | 1988-03-25 | 1989-10-12 | Bayer Ag | 7-substituierte 2-carbonamido-benzthiazol-3-oxide |
| DE4014937A1 (de) | 1990-05-10 | 1991-11-14 | Bayer Ag | 2,3-disubstituierte chinoxaline als leistungsfoerderer fuer tiere |
| GB9219634D0 (en) | 1992-09-16 | 1992-10-28 | Ici Plc | Heterocyclic compounds |
| GB9219632D0 (en) | 1992-09-16 | 1992-10-28 | Ici Plc | Heterocyclic compounds |
| EP0664792B1 (en) | 1992-10-14 | 2000-01-05 | Merck & Co. Inc. | Fibrinogen receptor antagonists |
| DE4237617A1 (de) | 1992-11-06 | 1994-05-11 | Bayer Ag | Verwendung von substituierten Benzimidazolen |
| GB9301660D0 (en) | 1993-01-28 | 1993-03-17 | Smithkline Beecham Plc | Pharmaceuticals |
| GB9306578D0 (en) | 1993-03-30 | 1993-05-26 | Merck Sharp & Dohme | Therapeutic agents |
| US6121274A (en) * | 1994-07-22 | 2000-09-19 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Dihydrobenzofurane |
| WO1996004251A1 (en) | 1994-08-03 | 1996-02-15 | Fujisawa Pharmaceutical Co., Ltd. | Heterocyclic compound |
| US5665737B1 (en) | 1994-10-12 | 1999-02-16 | Euro Celtique Sa | Substituted benzoxazoles |
| AU699489B2 (en) * | 1994-10-12 | 1998-12-03 | Euro-Celtique S.A. | Novel benzoxazoles |
-
1997
- 1997-11-17 ES ES97912370T patent/ES2200163T3/es not_active Expired - Lifetime
- 1997-11-17 KR KR1019990704253A patent/KR20000053274A/ko not_active Withdrawn
- 1997-11-17 SK SK644-99A patent/SK283534B6/sk unknown
- 1997-11-17 DE DE69722656T patent/DE69722656T2/de not_active Expired - Fee Related
- 1997-11-17 IL IL12933797A patent/IL129337A0/xx not_active IP Right Cessation
- 1997-11-17 CA CA002268037A patent/CA2268037A1/en not_active Abandoned
- 1997-11-17 CN CN97199650A patent/CN1114604C/zh not_active Expired - Fee Related
- 1997-11-17 WO PCT/GB1997/003154 patent/WO1998022460A1/en not_active Ceased
- 1997-11-17 TR TR1999/01730T patent/TR199901730T2/xx unknown
- 1997-11-17 JP JP52334598A patent/JP2001504479A/ja not_active Ceased
- 1997-11-17 HU HU0000189A patent/HUP0000189A3/hu unknown
- 1997-11-17 EP EP97912370A patent/EP0944616B1/en not_active Expired - Lifetime
- 1997-11-17 RU RU99112569/04A patent/RU2176642C2/ru not_active IP Right Cessation
- 1997-11-17 AU AU49602/97A patent/AU726590B2/en not_active Ceased
- 1997-11-17 ID IDW990356A patent/ID21698A/id unknown
- 1997-11-17 DK DK97912370T patent/DK0944616T3/da active
- 1997-11-17 CZ CZ991582A patent/CZ158299A3/cs unknown
- 1997-11-17 AT AT97912370T patent/ATE242234T1/de not_active IP Right Cessation
- 1997-11-17 BR BR9713507-0A patent/BR9713507A/pt unknown
- 1997-11-17 NZ NZ335197A patent/NZ335197A/xx unknown
-
1999
- 1999-05-14 NO NO992337A patent/NO992337D0/no not_active Application Discontinuation
- 1999-10-21 US US09/422,473 patent/US6353010B1/en not_active Expired - Fee Related
-
2002
- 2002-01-14 US US10/050,005 patent/US20020094987A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0000189A2 (hu) | 2001-04-28 |
| AU726590B2 (en) | 2000-11-09 |
| CN1237168A (zh) | 1999-12-01 |
| CA2268037A1 (en) | 1998-05-28 |
| ID21698A (id) | 1999-07-15 |
| DE69722656T2 (de) | 2004-05-13 |
| DK0944616T3 (da) | 2003-09-29 |
| ES2200163T3 (es) | 2004-03-01 |
| US6353010B1 (en) | 2002-03-05 |
| CN1114604C (zh) | 2003-07-16 |
| HUP0000189A3 (en) | 2002-01-28 |
| TR199901730T2 (xx) | 1999-09-21 |
| BR9713507A (pt) | 2000-02-29 |
| CZ158299A3 (cs) | 1999-09-15 |
| EP0944616A1 (en) | 1999-09-29 |
| NZ335197A (en) | 2000-11-24 |
| DE69722656D1 (de) | 2003-07-10 |
| ATE242234T1 (de) | 2003-06-15 |
| NO992337L (no) | 1999-05-14 |
| NO992337D0 (no) | 1999-05-14 |
| US20020094987A1 (en) | 2002-07-18 |
| AU4960297A (en) | 1998-06-10 |
| SK64499A3 (en) | 2000-03-13 |
| KR20000053274A (ko) | 2000-08-25 |
| EP0944616B1 (en) | 2003-06-04 |
| JP2001504479A (ja) | 2001-04-03 |
| SK283534B6 (sk) | 2003-09-11 |
| WO1998022460A1 (en) | 1998-05-28 |
| RU2176642C2 (ru) | 2001-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL129337A0 (en) | Bicyclic aryl carboxamides and their therapeutic use | |
| MX9800922A (es) | Quinolonas y su uso terapeutico. | |
| MX9800921A (es) | Quinolonas y su uso terapeutico. | |
| AU3102697A (en) | Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase | |
| MY111201A (en) | New imidazopyridines | |
| DE69723447D1 (de) | Substituierte indazolderivate und ihre verwendung als inhibitoren des phosphodiesterase (pde) typs 4 und des tumor-necrosin-factors (tnf) | |
| ZA981936B (en) | Novel benzimidazole inhibitors of fructose 1,6-bisphosphatase. | |
| GB9514473D0 (en) | Chemical compounds | |
| FI943805L (fi) | Substituoituja adeniinijohdannaisten käyttö multippeliskleroosin hoitoon | |
| HUT74589A (en) | Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor | |
| AU4873193A (en) | Use of substituted benzimidazoles | |
| AU2228297A (en) | Use of isoniazid for the treatment of hyperlipoproteinemia | |
| ID18679A (id) | Penggunaan terapi lanjutan | |
| PL315666A1 (en) | Heterocyclic compounds of therapeutic properties | |
| HUP9903506A3 (en) | Use of griseofulvin for inhibiting the growth of cancers | |
| IL131407A0 (en) | Tetrahydropyrido compounds medicaments containing the same and the use thereof | |
| HUP9902557A3 (en) | Use of polymers as biocides | |
| IL150125A0 (en) | Novel compounds | |
| AU7310896A (en) | Use of nitroflavonoids for the treatment of anxiety | |
| AU4712696A (en) | The use of heterocyclic compounds | |
| ZA932553B (en) | New use of B-carbolines | |
| GB9222985D0 (en) | Use of the tarchonanthus camphoratus | |
| IL99705A0 (en) | Inhibitors for the formation of tumor necrosis factor,processes for the preparation thereof and the use thereof | |
| AU4825993A (en) | New compounds for use in the treatment of cancer | |
| NZ255753A (en) | Use of substituted azaspiranes for psoriasis treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |